Introduction Congenital heart disease (CHD) affects around 1% of pregnancies in the UK each year. Around half of these are major cardiac lesions requiring surgery or intervention within the 1st year of life. Studies show that if CHD is detected before birth, there are significant benefits for babies, their families and for medical services around the time of birth and in the first year of life. Prenatal diagnosis and appropriate treatment may prevent the devastating consequences of early circulatory collapse, such as death and ischaemic brain damage. Background An audit previously conducted in our district general hospital found that the antenatal detection rate of significant cardiac lesions in Jan 1998–Dec 1999 was 17.6%. Following this, new ultrasound machines were purchased and ultrasonographers received training to perform outlet views of the fetal heart as well as 4 chamber views. Aims The aims of this audit were 1) to establish whether this intervention has led to improved antenatal detection of significant CHD and 2) to compare these detection rates with national figures. Methods Antenatal detection rates of CHD were again audited for all babies who received an anomaly scan in Jan 2009–Dec 2010. Children with significant CHD were identified through their attendance at cardiac clinic. We then looked retrospectively at each child’s anomaly scan (18+0 – 20+6 weeks gestation) and recorded whether or not a cardiac lesion had been detected antenatally. We also reviewed data from the South West Congenital Anomoly Register (SWCAR) and local electronic and paper records by which method we were able to include antenatally detected significant CHD in foetuses who did not survive. Results Following the intervention antenatal detection of significant CHD rose to 72%. This compares with national detection rates of around 30% over the same period. Conclusion Our findings confirm the necessity of cardiac outlet views along side 4-chamber views as part of antenatal anomaly scanning with good supervision and support from local and regional Fetal Medicine Specialists.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.